238 related articles for article (PubMed ID: 19419314)
1. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling.
Sotillo Rodriguez JE; Mansky KC; Jensen ED; Carlson AE; Schwarz T; Pham L; MacKenzie B; Prasad H; Rohrer MD; Petryk A; Gopalakrishnan R
J Bone Miner Res; 2009 Nov; 24(11):1917-26. PubMed ID: 19419314
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 2 signaling in osteoclasts is negatively regulated by the BMP antagonist, twisted gastrulation.
Pham L; Beyer K; Jensen ED; Rodriguez JS; Davydova J; Yamamoto M; Petryk A; Gopalakrishnan R; Mansky KC
J Cell Biochem; 2011 Mar; 112(3):793-803. PubMed ID: 21328453
[TBL] [Abstract][Full Text] [Related]
3. The Function of Twisted Gastrulation in Regulating Osteoclast Differentiation is Dependent on BMP Binding.
Huntley R; Davydova J; Petryk A; Billington CJ; Jensen ED; Mansky KC; Gopalakrishnan R
J Cell Biochem; 2015 Oct; 116(10):2239-46. PubMed ID: 25808976
[TBL] [Abstract][Full Text] [Related]
4. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
Omi M; Kaartinen V; Mishina Y
J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
6. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors.
Jensen ED; Pham L; Billington CJ; Espe K; Carlson AE; Westendorf JJ; Petryk A; Gopalakrishnan R; Mansky K
J Cell Biochem; 2010 Mar; 109(4):672-82. PubMed ID: 20039313
[TBL] [Abstract][Full Text] [Related]
8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
9. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
[TBL] [Abstract][Full Text] [Related]
10. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
[TBL] [Abstract][Full Text] [Related]
12. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
13. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW
J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968
[TBL] [Abstract][Full Text] [Related]
15. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro.
Wutzl A; Rauner M; Seemann R; Millesi W; Krepler P; Pietschmann P; Ewers R
J Orthop Res; 2010 Nov; 28(11):1431-9. PubMed ID: 20872578
[TBL] [Abstract][Full Text] [Related]
17. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
18. HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation.
Wu X; Chim SM; Kuek V; Lim BS; Chow ST; Zhao J; Yang S; Rosen V; Tickner J; Xu J
FEBS Lett; 2014 Jan; 588(1):143-50. PubMed ID: 24269886
[TBL] [Abstract][Full Text] [Related]
19. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.
Usui M; Xing L; Drissi H; Zuscik M; O'Keefe R; Chen D; Boyce BF
J Bone Miner Res; 2008 Mar; 23(3):314-25. PubMed ID: 17967138
[TBL] [Abstract][Full Text] [Related]
20. The expression of twisted gastrulation in postnatal mouse brain and functional implications.
Sun M; Forsman C; Sergi C; Gopalakrishnan R; O'Connor MB; Petryk A
Neuroscience; 2010 Aug; 169(2):920-31. PubMed ID: 20493240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
